CDXS
Codexis, Inc.
$2.85
+10.47%
2026-05-08
About Codexis, Inc.
Codexis, Inc. provides technology solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, enhance, and commercialize novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route. It has a license agreement with Aldevron LLC and Pfizer Inc. The company was incorporated in 2002 and is headquartered in Redwood City, California.
Key Fundamentals
Forward P/E
-7.05
EPS (TTM)
$-0.50
ROE
-74.9%
Revenue Growth (YoY)
81.3%
Profit Margin
-62.5%
Debt/Equity
144.88
Price/Book
4.80
Beta
2.53
Market Cap
$243.6M
Avg Volume (10D)
1.4M
Recent Breakout Signals
No recent breakout signals detected for CDXS.
Recent Price Range (60 Days)
60D High
$2.92
60D Low
$0.96
Avg Volume
2.3M
Latest Close
$2.85
Get breakout alerts for CDXS
Sign up for Breakout Scanner to receive daily notifications when CDXS triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
Codexis, Inc. (CDXS) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors CDXS daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. CDXS operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.